|
|
Ferro Holdings LLC is a family owned holding company focused on managing the investments of and operating the owned businesses of the Ferro family. Ferro Holdings is the successor entity of Vatera Capital Management. The firm makes both direct healthcare investments and allocations to third party managers, and invested across the full range of asset classes, including traditional sectors, such as equities, fixed income, commodities and real estate, and alternative investment strategies, such as hedge funds and private equity funds. Kevin Ferro is the founder of Ferro Holdings LLC, a family-owned holding company formed in 2019 and based in Florida. He was previously chairman of the board of directors of Pearl Therapeutics, a clinical stage company focused on the development of therapies for chronic respiratory diseases, until its sale to AstraZeneca for up to $1.2 billion, and served as a member of the board of directors of Kos Pharmaceuticals, a specialty pharmaceutical company focused on the treatment of chronic cardiovascular, metabolic and respiratory diseases, until its sale to Abbott Labs for $4.2 billion. He currently serves on the Board of Trustees of Prep for Prep, a leadership development program offering promising students of color from modest backgrounds access to private school education. Mr. Ferro is also a member of the Board of Trustees of Pine Crest School in Fort Lauderdale.
|
